123 related articles for article (PubMed ID: 19036691)
1. Trends in chemotherapy utilization for colorectal cancer.
Renouf D; Kennecke H; Gill S
Clin Colorectal Cancer; 2008 Nov; 7(6):386-9. PubMed ID: 19036691
[TBL] [Abstract][Full Text] [Related]
2. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
3. Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma.
Elsaleh H; Iacopetta B
Clin Colorectal Cancer; 2001 Aug; 1(2):104-9. PubMed ID: 12445368
[TBL] [Abstract][Full Text] [Related]
4. Deleted in colorectal cancer protein expression as a possible predictor of response to adjuvant chemotherapy in colorectal cancer patients.
Gal R; Sadikov E; Sulkes J; Klein B; Koren R
Dis Colon Rectum; 2004 Jul; 47(7):1216-24. PubMed ID: 15148649
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of perineural invasion in patients with stage II colorectal cancer.
Huh JW; Kim HR; Kim YJ
Ann Surg Oncol; 2010 Aug; 17(8):2066-72. PubMed ID: 20182809
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of adjuvant chemotherapy in patients with colorectal cancer in Primorsko-Goranska and Istarska County--a twenty years retrospective study.
Belac-Lovasić I; Petković M; Ferrari AM; Lovasić F; Grbas H
Coll Antropol; 2011 Sep; 35 Suppl 2():111-4. PubMed ID: 22220416
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant treatment in colorectal cancer. Experience from a referral center in eastern peninsular Malaysia.
Biswal BM; Sain AH; Othman NH; Baba A
Trop Gastroenterol; 2002; 23(3):134-7. PubMed ID: 12693156
[TBL] [Abstract][Full Text] [Related]
8. Deleted in colon cancer protein expression in colorectal cancer metastases: a major predictor of survival in patients with unresectable metastatic disease receiving palliative fluorouracil-based chemotherapy.
Aschele C; Debernardis D; Lonardi S; Bandelloni R; Casazza S; Monfardini S; Gallo L
J Clin Oncol; 2004 Sep; 22(18):3758-65. PubMed ID: 15365072
[TBL] [Abstract][Full Text] [Related]
9. Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer.
Cronin DP; Harlan LC; Potosky AL; Clegg LX; Stevens JL; Mooney MM
Am J Gastroenterol; 2006 Oct; 101(10):2308-18. PubMed ID: 17032196
[TBL] [Abstract][Full Text] [Related]
10. Patterns of care for European colorectal cancer patients diagnosed 1996-1998: a EUROCARE high resolution study.
Gatta G; Zigon G; Aareleid T; Ardanaz E; Bielska-Lasota M; Galceran J; Góźdź S; Hakulinen T; Martinez-Garcia C; Plesko I; Zakelj MP; Rachtan J; Tagliabue G; Vercelli M; Faivre J
Acta Oncol; 2010 Aug; 49(6):776-83. PubMed ID: 20429733
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX.
Chang MH; Lee IK; Si Y; Lee KS; Woo IS; Byun JH
Cancer Chemother Pharmacol; 2011 Aug; 68(2):317-23. PubMed ID: 20972872
[TBL] [Abstract][Full Text] [Related]
12. Clinical impact of adjuvant chemotherapy on patients with stage III colorectal cancer: l-LV/5FU chemotherapy as a modified RPMI regimen is an independent prognostic factor for survival.
Hotta T; Takifuji K; Arii K; Yokoyama S; Matsuda K; Higashiguchi T; Tominaga T; Oku Y; Yamaue H
Anticancer Res; 2006; 26(2B):1425-32. PubMed ID: 16619554
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant chemotherapy for stage III colon cancer: does timing matter?
Czaykowski PM; Gill S; Kennecke HF; Gordon VL; Turner D
Dis Colon Rectum; 2011 Sep; 54(9):1082-9. PubMed ID: 21825887
[TBL] [Abstract][Full Text] [Related]
14. Role of desmoplasia in recurrence of stage II colorectal cancer within five years after surgery and therapeutic implication.
Crispino P; De Toma G; Ciardi A; Bella A; Rivera M; Cavallaro G; Polistena A; Fornari F; Unim H; Pica R; Cassieri C; Mingazzini PL; Paoluzi P
Cancer Invest; 2008 May; 26(4):419-25. PubMed ID: 18443963
[TBL] [Abstract][Full Text] [Related]
15. Half of elderly patients routinely treated for colorectal cancer receive a sub-standard treatment.
Aparicio T; Navazesh A; Boutron I; Bouarioua N; Chosidow D; Mion M; Choudat L; Sobhani I; Mentré F; Soulé JC
Crit Rev Oncol Hematol; 2009 Sep; 71(3):249-57. PubMed ID: 19131256
[TBL] [Abstract][Full Text] [Related]
16. Circulating nucleosomes and cytokeratin 19-fragments in patients with colorectal cancer during chemotherapy.
Holdenrieder S; Holubec L; Topolcan O; Finek J; Stieber P
Anticancer Res; 2005; 25(3A):1795-801. PubMed ID: 16033102
[TBL] [Abstract][Full Text] [Related]
17. Patterns of diagnosis for colorectal cancer: screening detected vs. symptomatic presentation.
Smiljanic S; Gill S
Dis Colon Rectum; 2008 May; 51(5):573-7. PubMed ID: 18299931
[TBL] [Abstract][Full Text] [Related]
18. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
Secord AA; Havrilesky LJ; O'Malley DM; Bae-Jump V; Fleming ND; Broadwater G; Cohn DE; Gehrig PA
Gynecol Oncol; 2009 Sep; 114(3):442-7. PubMed ID: 19560193
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcome for synchronous locoregional failures of nasopharyngeal carcinoma.
Chua DT; Wei WI; Sham JS; Cheng AC; Au G
Head Neck; 2003 Jul; 25(7):585-94. PubMed ID: 12808662
[TBL] [Abstract][Full Text] [Related]
20. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
